Search
for
Sort by
Research 31–60 of 551
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- Treatment of actinic cheilitis with ingenol mebutate gel: Experience in four patients
- Medical management of benign prostatic hyperplasia
- Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting
- Study of QuantiFERON’S conversion/reversal phenomena in patients with psoriasis during biological treatment
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- 8 Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence
- Approaching Erectile Dysfunction in Dermatology Patients
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- INTERACTION OF α-MELANOCYTE-STIMULATING HORMONE, MELATONIN, CYCLIC AMP AND CYCLIC GMP IN THE CONTROL OF MELANOGENESIS IN HAIR FOLLICLE MELANOCYTES IN VITRO
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss
- The ‘bald’ phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral ‘western diet’
- 873 The effect of Cilostazol on hair growth: A novel therapeutic option for the treatment of hair loss
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- Anti‐hair loss effect of a shampoo containing caffeine and adenosine
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- When two plus two must not equal four
- Apremilast for extensive and treatment-resistant alopecia areata: a retrospective analysis of five patients
- From bench to babies – drug development for male subfertility
- Lower Urinary Tract Symptoms: What’s New in Medical Treatment?
- ENZYMES
- Lower Urinary Tract Symptoms in Men